ARVO 2025
START-END May 5, 2025 from 8:30 AM to 10:15 AM MDT
Poster Presentations:
Title: Baseline Characteristics of Adolescent Stargardt Disease Subjects Participating in a Phase 3 Study of Tinlarebant (DRAGON Trial)
Presenting Author: Dr. Ruifang Sui
Presentation Number: 1463
Session Number: 215
Session Title: Retinitis Pigmentosa and IRD I
Session Date/Time: Monday, May 5, 8:30-10:15 a.m. MDT
Title: Pharmacokinetic and Pharmacodynamic Properties of an Oral Investigational Treatment for Stargardt Disease in Adolescent Japanese Patients
Presenting Author: Dr. Kaoru Fujinami
Presentation Number: 1431
Session Number: 215
Session Title: Retinitis Pigmentosa and IRD I
Session Date/Time: Monday, May 5, 8:30-10:15 a.m. MDT